Best Startup
At Best Startup US we track over 1,000,000 US startups and over 3 million people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United States based President operating in the Medical Device space. If you think a President is missing from this list, feel free to contact our editor on editor@beststartup.us.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Rukiya Packer
Vice President of Vitality Medical
Rukiya Packer is the Vice President at Vitality Medical.
Follow Rukiya Packer:
About Vitality Medical: Vitality Medical provides quality home medical supplies and hospital equipment.
_______
Adam Dunn
Vice President Information Technology Operations of Vitality Medical
Adam is a full time problem solver. He graduated from Brigham Young University in 2010 with a B.S. in Information Science and Technology and later graduated with his M.S. in Information Systems from Utah University in 2013. Since starting with Vitality Medical in 2009, Adam assumes the role of IT Director by using his web experience to improve customer’s online experience. Before working at Vitality Medical, Adam worked as an Operations Specialist for a local credit union where he managed web development and online processes to streamline consumer loans.
Follow Adam Dunn:
About Vitality Medical: Vitality Medical provides quality home medical supplies and hospital equipment.
RJ Fitch
Vice President Operations & General Manager of WuXi AppTec
Innovative senior management leader Raymond J. “RJ” Fitch possesses more than two decades of experience in the biotech and global healthcare industries. As the Vice President of Operations & General Manager for WuXi AppTec Advanced Therapies, Mr. Fitch leverages his knowledge of site operations and supply chain functions to oversee logistics operations, biological testing services, engineering, and other operations at the company’s Philadelphia location. RJ Fitch is responsible for three facilities within the Philadelphia site. Mr. Fitch began his career more than 20 years ago, graduating from Philadelphia University with a bachelor of science in biology. After working for Merck & Company, he joined Sanofi Pasteur as a director of vaccine aseptic filling & formulation. He stayed with the company for seven years, rising through the ranks to become the senior director of influenza viral manufacturing. Mr. Fitch later served as the associate vice president at Genzyme, a Sanofi company, and vice president of Sanofi Pasteur in Toronto, Canada. During his time with Sanofi Pasteur, RJ Fitch returned to school to earn an executive MBA from the New York University Stern School of Business.
Follow RJ Fitch:
About WuXi AppTec: WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical.
Richard Kolodny
President of Drive Medical
Richard Kolodny is a principal founder of the Company. Richard joined the Company in April 2003 as Executive Vice President, Chief Financial Officer and General Counsel, and became President in 2008. From 1999 through March 2003, Richard was a corporate partner in the law firm of Jenkens & Gilchrist Park Chapin, LLP. Richard specialized in the areas of general corporate and securities laws. From 1993 through 1999, Richard served as the Executive Vice President and General Counsel of a publicly traded healthcare company where he served as a member of the Board of Directors of such company’s domestic and international operating companies. Prior to such time, Richard was associated with the New York law firm of Shea and Gould.
Follow Richard Kolodny:
About Drive Medical, Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Joseph Lewarski
Senior Vice President/General Manager, Clinical Care & North America Manufacturing of Drive Medical
Follow Joseph Lewarski:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Karen Lerner
Regional Vice President of Pressure Prevention of Drive Medical
Karen is a registered nurse, wound care and rehab specialist with over 25 years of industry experience. Karen has extensive experience as a public speaker, educating DME providers and clinicians on a variety of topics. Karen’s speaking engagements included testifying before Congress on behalf of the HME industry. Since October 2013, Karen has worked as part of Team Pressure Prevention at Drive Medical. Prior to coming to Drive and for over 10 years, Karen was VP of Clinical Services at a Northeast based DME, responsible for Pressure Prevention, Respiratory and Rehab sales, as well as service and training. Before DME, Karen worked in sales for a hospital equipment and support surface manufacturer. Karen began her career as a critical care nurse specialist in major teaching hospitals from Florida to NJ. Karen received her undergraduate degree from Duke University and her graduate education from the University of Florida.
Follow Karen Lerner:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Josh Gordon
Vice President of Inside Sales for North America of Drive Medical
After graduating from Penn State University in 1999, Joshua Gordon spent several years growing a sales portfolio in recruiting and admissions for the Katharine Gibbs School. Josh joined Drive Medical in 2002 as a Territory Business Manager for the Philadelphia Region. In 2009, Josh took his experience from outside sales and developed a new Inside Sales Department for the company.
Follow Josh Gordon:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Michael Serhan
Executive Principal & Executive Vice President of Product Development of Drive Medical
Michael Serhan is an Executive principal to Drive Medical. Michael joined the company in 2004, with the Company’s merger of Dr. K international, a West Coast manufacturer and distributor of durable medical products, where he served as President and Principal stock holder. At Dr.K, Mr. Serhan was able to redirect the company’s direction and grow annual revenues to approximately $14 million. In the industry from 1987, Michael has served as West Coast division President of an approximately $180 Million publicly traded company. Michael is primarily responsible for product development and product design, overseeing core product categories, and handling large national customers for Drive Medical.
Follow Michael Serhan:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Ryan Mahoney
Regional Vice President – Midwest Sales Division of Drive Medical
A graduate from University of Dayton and previously working for a homecare provider in the Pittsburgh market, Ryan joined Drive Medical in 2009 as a Territory Manager for Western Pennsylvania. With a highly successful territory, Ryan earned the 2010 Rookie of the Year award, the 2011 Rep of the year award and was promoted in 2012 to Vice President of Sales for Drive’s Midwest division.
Follow Ryan Mahoney:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Jeffrey Schwartz
Executive Vice President of Sales of Drive Medical
Jeffrey Schwartz is a principal founder of Drive medical. Jeffrey served as the Vice President of Sales of Diamond Medical and National Healthcare from 1987 until 1992. Following the sale to a publicly traded healthcare company, Jeffrey served as the Vice President of Sales of such public company until 1996. In 1996, Jeffrey formed Jofra Enterprises, Inc., a distributor of medical products, located in Mt. Vernon, New York, which was subsequently acquired by a publicly traded healthcare company in 1998. Jeffrey served as the Executive Vice President of Sales of the publicly traded healthcare company from 1998 through 2000.
Follow Jeffrey Schwartz:
About Drive Medical, Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Rowley Jackson
Senior Vice President of Corporate Accounts of Drive Medical
Rowley Jackson has been in the medical products industry for over 25 years and has served in many capacities from managing sales to product development. Rowley has been with Drive Medical since the beginning. He was the first vendor for Drive, supplying product from a domestic manufacturer where he served as the Executive Vice president. Rowley joined Drive in January of 2001 to create its initial sales force.
Follow Rowley Jackson:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Seth Diamond
Vice President of Ecommerce Division of Drive Medical
Seth Diamond has been part of the Drive team since its inception. In his tenure, Seth has held many roles and his diverse contributions have made him an integral factor in Drive success. His knowledge of durable medical equipment, sales experience and background in Ecommerce has allowed him to flourish as V.P. of the Ecommerce Division. Seth’s responsibilities include the management and development of the Drive brand via the World Wide Web.
Follow Seth Diamond:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Greg Eaton
Regional Vice President of Respiratory Sales of Drive Medical
Greg Eaton started with Drive Medical in July of 2015 through the acquisition of DeVilbiss Healthcare. Greg brings over 29 years of medical sales and sales management experience in Orthopedics, Spine, Sleep and Respiratory. Greg started his medical career with Medtronic as a territory sales manager in Indianapolis, and earned President’s Club honors in his first year. Medtronic promoted him to management covering the Southeast District based out of North Carolina. Greg then moved to a start up territory opportunity with ResMed, specializing in sleep disordered breathing. During his tenure, Greg was instrumental in growing a small market of less than $500,000 annual sales to a market of $50 million and was honored with 5 President’s Club awards. Greg then accepted an opportunity in the Spine industry with Orthofix as the Regional Director. His leadership took the Mid-Atlantic Region to 3 consecutive years as Region of the Year and President’s Club honors. After his time with Orthofix, Greg was recruited back to the Sleep and Respiratory industry by Devilbiss Healthcare as the Eastern Region Manager.
Follow Greg Eaton:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Francheska Markman
Vice President of Customer Service of Drive Medical
Francheska Markman is a Customer Service and Call Center professional with over 18 years of experience. Most recently, Francheska led and directed a 65-seat Customer Service and Accounts Receivable Departments at Southern Wine and Spirits, a mutli-million dollar national distributor of adult beverages. Francheska has been recognized for her strength in strategic work flow planning, managerial expertise of a fast paced, high volume call center, resourcefulness and commitment to success.
Follow Francheska Markman:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Tony Crisitello
Senior Vice President of Long Term Care of Drive Medical
Tony Crisitello joined Drive Medical in 2014 as Senior Vice President – Long Term Care. Tony responsible for strategic development and growth of this division through both acquisitions and organic growth in North America. Prior to joining Drive Medical, Tony was Co-Founder and President of Next Day Medical, a regional distribution business based in Baltimore, MD. Tony sold this business to McKesson Medical Surgical in 2012, and held various leadership positions in their organization during the two year integration period of Next Day Medical. Tony holds a degree in marketing from Old Dominion University and has attended several executive level programs at NYU Stern School of Business, Stanford Graduate School of Business, and Duke University’s Fuqua School of Business.
Follow Tony Crisitello:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Vanessa Saltmarsh
Regional Vice President of Drive Medical
Vanessa Saltmarsh joined Drive Medical in 2012 as the Director of Respiratory Business Services. In this role, she called on her 16+ years of industry related experience to provide direction and leadership to key accounts. Prior to joining Drive Medical, Vanessa began her career at evo Medical Solutions, where she took on progressively responsible roles in the areas of sales, marketing, and operational management. Vanessa has been recognized as a leader in respiratory sales, program development and strategic account management. In August 2015, Vanessa was promoted to Regional Vice President of Respiratory Sales, where she owns responsibility for key account management, training, marketing communications content, and salesforce clinical support for Drive’s respiratory category.
Follow Vanessa Saltmarsh:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Thomas Antonio
Vice President of Financial & CFO of Drive Medical
Thomas Antonio joined the Company in February 2004, and is primarily responsible for financial reporting. From 1986 through 1997, Thomas Antonio served as the Assistant Vice President and Controller of Charan Industries, a privately-held company which owned and operated bowling centers throughout the United States. From 1997 through February 2004, Thomas served as the Chief Financial Officer of several privately-held companies located in the metropolitan New York area.
Follow Thomas Antonio:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Dan O’Malley
Regional Vice President of Pressure Prevention Sales of Drive Medical
Dan O’Malley joined Drive Medical in 2013, as Regional VP of Pressure Prevention Sales in connection with the Company’s acquisition of a national manufacturer of durable medical products. Dan is primarily responsible for the Company’s category sales in Pressure Prevention for the homecare and long term care markets. Dan has 20 years of experience working in the acute care, long term care, and homecare settings in the medical device, rehabilitation, and durable medical equipment industries. More recently, Dan served as the National Sales Manager for Mason Medical Products, a manufacturer of Pressure Prevention products. Dan is a 1995 graduate of the University of Massachusetts.
Follow Dan O’Malley:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Steve Wakser
Vice President of Sales for Southeast of Drive Medical
Steve Wakser started with Drive in January 2009, with over 10 years of experience in the DME industry running a successful dealership in Ohio. Steve quickly grew his Michigan territory to top numbers and achieved Rookie of the Year in 2009 and Rep of the Year in 2010, with over $6 million in sales. Continued success led Steve to Regional Vice President of the Southeast in 2012. Steve holds a Bachelors Degree in Communications from Kent State University.
Follow Steve Wakser:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Jim McGuiness
Vice President of Sales – Retail Division of Drive Medical
Jim McGuiness joined Drive Medical in March of 2010. Jim brings over 25 years of executive sales leadership experience from the Consumer Package Goods industry (GSK & Bayer Consumer Healthcare). Jim is a graduate of LSU and currently resides in Dallas, Texas. Jim is responsible for leading the Retail Sales Division for Drive Medical.
Follow Jim McGuiness:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Christopher Cheek
Vice President of Distributor Sales of Drive Medical
Christopher Cheek joined Drive Medical in July of 2014 as Vice President of Distributor Sales through the acquisition of MEDQUIP Inc. Christopher brings with him over 25 years of successful experience within the medical products industry and has specialized in distributor-wholesale partner management for most of his profession. In January 2006, Christopher joined MEDQUIP shortly after its inception as National Sales Manager and relocated to the company’s headquarters in South Carolina in 2008, where Christopher served as the organization’s Vice President and General Manager. Throughout his career, Christopher has served in many capacities within the industry including Director of Business Development for a major manufacturer and distributor of orthotic braces, compression hosiery and durable medical equipment. Other positions held include National Sales Manager of a leading Medical Hosiery Manufacturer. Christopher’s experience within the industry is comprised of an extensive history within the business and has a strong acumen in sales management, marketing, product development, sales training and continuing education.
Follow Christopher Cheek:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Christopher Cheek
Vice President of Distributor Sales of Drive Medical
Christopher Cheek joined Drive Medical in July of 2014 as Vice President of Distributor Sales through the acquisition of MEDQUIP Inc. Christopher brings with him over 25 years of successful experience within the medical products industry and has specialized in distributor-wholesale partner management for most of his profession. In January 2006, Christopher joined MEDQUIP shortly after its inception as National Sales Manager and relocated to the company’s headquarters in South Carolina in 2008, where Christopher served as the organization’s Vice President and General Manager. Throughout his career, Christopher has served in many capacities within the industry including Director of Business Development for a major manufacturer and distributor of orthotic braces, compression hosiery and durable medical equipment. Other positions held include National Sales Manager of a leading Medical Hosiery Manufacturer. Christopher’s experience within the industry is comprised of an extensive history within the business and has a strong acumen in sales management, marketing, product development, sales training and continuing education.
Follow Christopher Cheek:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Deepak Nath
President, Laboratory Diagnostics of Siemens Healthineers
Follow Deepak Nath:
About Siemens Healthineers: Siemens Healthineers is a healthcare technology company that provides diagnostic and therapeutic products and services.
Ron Pellegrini
Vice President & Head of Field Service LD/POC of Siemens Healthineers
Ron Pellegrini’s career with Siemens Healthcare spans over 20 years. It began as a licensed Medical Technologist specializing in Chemistry with the U.S. Air Force and at hospitals in Dallas / Fort Worth area. His experience led him to an engineering position with Ciba-Corning Diagnostics. He has held the position of Regional Service Manager and Technical Sales Manager for Chiron & Bayer Healthcare. He held the role of National Technical Sales Director at Siemens and was a Zone Vice President in the Midwest & Western Zones for both the In Vivo and In Vitro businesses prior to taking on his recent role as Vice President, Head of Field Service for LD/POC. Ron was awarded Rookie of the Year, Regional Manager & Director of the year, a three time President’s Club award winner and VP of the Year and a four time APEX winner while in his Service and Technical Sales Leadership positions. He is member of the American Medical Technologists (AMT), a mentor with the American Corporate Partners (ACP) for US Military Members, and is very active as a volunteer within his church community. Ron has been married for the past 29 years with four beautiful children. He enjoys traveling, golf and the watching the Dallas Cowboys. He holds Bachelors degree in Medical Technology from Midwestern State University in Wichita Falls, TX and has a Masters degree in Business.
Follow Ron Pellegrini:
About Siemens Healthineers: Siemens Healthineers is a healthcare technology company that provides diagnostic and therapeutic products and services.
Maynd Jolly
Vice President Strategic Corporate Accounts of Siemens Healthineers
Follow Maynd Jolly:
About Siemens Healthineers: Siemens Healthineers is a healthcare technology company that provides diagnostic and therapeutic products and services.
Sebastian Kronmueller
Vice President, Head of Strategy & Business Development – Laboratory Diagnostics of Siemens Healthineers
Sebastian Kronmueller incubates startup businesses within Healthineers with a focus on novel molecular applications. His current incubation businesses include the Siemens Healthcare Laboratory in Berkeley, California and NEO New Oncology in Cologne, Germany. Previously he led the execution of strategic initiatives as Head of Special Projects for Siemens Healthineers, playing an instrumental role in shaping the strategy of Siemens Healthineers in preparation for the IPO planned in 2018. Before this role he led a project management team for companion diagnostics and software development and was responsible for the carve-out and divestment of the Healthineers Microbiology business. He began his career as strategy consultant with Siemens Management Consulting. Sebastian holds a graduate degree in physics from Ludwig-Maximilians-University in Munich, Germany and a graduate certificate in Management Science and Engineering from Stanford University in Palo Alto, California.
Follow Sebastian Kronmueller:
About Siemens Healthineers: Siemens Healthineers is a healthcare technology company that provides diagnostic and therapeutic products and services.
Ros Deegan
President and Chief Business Officer of Bicycle Therapeutics
Ros Deegan, MBA, is president and chief business officer of Bicycle Therapeutics Inc., the U.S. subsidiary of Bicycle Therapeutics. Prior to joining Bicycle, Ros most recently served on the senior leadership team at Trevena, Inc. as senior vice president, business development and operations, and previously held the role of head of finance and operations. While at Trevena, she was responsible for start-up operations, negotiating a significant option and license agreement with Forest Laboratories, Inc., and leading finance and human resources through to the company’s first S-1 filing with the Securities and Exchange Commission. During her tenure, the company moved three programmes into the clinic, and raised over $200 million in private and public financings. Prior to joining Trevena, Ros served as director of business development at GSK in the U.S., leading transactions for the virtual immuno-inflammation group. Prior to that, she served as the director of operations for the Centre of Excellence for External Drug Discovery (CEEDD) and as marketing manager for GSK’s U.K. launch of Bonviva for post-menopausal osteoporosis and in business development. Ros holds a first-class degree from Cambridge University and received her MBA with distinction from INSEAD.
Follow Ros Deegan:
About Bicycle Therapeutics, Creative Destruction Lab (CDL), OMass Technologies: Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.
Chad Clark
President of Precision for Medicine
Chad Clark is the President at Precision for Medicine.
Follow Chad Clark:
About Precision for Medicine, Precision Medicine Group: Precision for Medicine is a specialized scientific services company helping life science innovators develop medical products.
Jared Kohler
Sr. Vice President, Project Management & Data Science Operations & Precision for Medicine of Precision for Medicine
Jared Kohler is the Sr. Vice President, Project Management & Data Science Operations, Precision for Medicine at Precision for Medicine.
Follow Jared Kohler:
About Precision for Medicine, Quartz Bio: Precision for Medicine is a specialized scientific services company helping life science innovators develop medical products.
Merry Lee
Vice President, Medical Device Regulatory Strategy of Precision for Medicine
Merry Lee Bain is the Vice President, Medical Device Regulatory Strategy at Precision for Medicine.
Follow Merry Lee:
About Precision for Medicine: Precision for Medicine is a specialized scientific services company helping life science innovators develop medical products.
Maury Blackman
President & CEO of Premise Data
Maury Blackman is CEO of Premise Data. Blackman is a tech executive with more than 25 years of experience leading high growth enterprise software companies. His industry experiences include government, construction, public safety, geospatial information, GPO’s, sharing economy services, and drone software. Blackman joined Premise in 2017; under his leadership the company has seen 661% revenue growth. In November 2020, Premise was named to Deloitte’s Technology Fast 500, a list of the 500 fastest-growing technology, media, telecommunications, life sciences and energy tech companies in North America. Premise is the 35th fastest-growing company in the Silicon Valley region and is 182nd on the overall list. Before joining Premise, Blackman was CEO at Accela, a civic tech company aimed at moving citizen transactions from city hall to online and mobile services. He joined the company in 2000 as the VP of Sales and Marketing and then assumed the role of CEO in 2007. To support strategic initiatives and growth, he raised more than $300M in financing from family offices, private equity, and senior debt. The capital from these raises was deployed to build out an enterprise offering, expand internationally, and execute an M&A strategy that closed 10+ acquisitions in 24 months. Prior to joining Accela, Maury worked for Investools (NASDAQ:IEDU) where he served in several executive positions from 1993 to 2000. At Investools, he first joined as an Account Executive and was later appointed Vice President, Business Development charged with selling data and content to brokerage firms and internet service providers in the nascent dot-com era. In this capacity, he built a dynamic portfolio of accounts that included Charles Schwab, Fidelity, AOL, and Netcom Online Communications. For his accomplishments at Accela, Blackman was recognized by Government Technology as one of its Top 25 Doers, Dreamers, and Drivers in 2015. In 2016, Ernst and Young awarded him the prestigious Northern California’s Entrepreneur of the Year. Maury holds a B.A. in Political Science from the University of Houston and was a commissioned field artillery officer in the United States Army, serving on both active and reserve duty for 10 years. Maury maintains an active lifestyle and is an eleven-time Ironman finisher, including the 2008 and 2013 Ironman World Championship in Kailua-Kona.
Follow Maury Blackman:
About Premise Data: Premise is a data and analytics platform powered by a global network of on-the-ground contributors, data science, and machine learning.
Gioel Molinari
Executive Vice President & Chief Product Officer of Butterfly Network
Follow Gioel Molinari:
About Butterfly Network: Butterfly Network designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment.
Andrew Song
President and Co-Founder of Whisper
Andrew Song is the President and Co-Founder at Whisper.
Follow Andrew Song:
About Whisper: Whisper develops AI-enabled, updateable hearing aids for people with hearing loss.
Kim D. Blickenstaff
President and Chief Executive Officer of Tandem Diabetes Care
Kim joined Tandem in August 2007, bringing more than 30 years of healthcare experience in finance, marketing management, sales and strategic planning. Prior to joining Tandem, he was Chairman, Chief Executive Officer and co-founder of Biosite Incorporated, a medical diagnostic company that was acquired by Inverness Medical Innovations for $1.8 billion in June 2007. Prior to founding Biosite, he held various finance, operations, research management, sales management, strategic planning and marketing positions with Hybritech Incorporated and Baxter Healthcare. Kim has been active in the medical device and diagnostics industry over the last 12 years, serving on the board of directors for innovative, young healthcare companies such as SenoRx and MediVation Incorporated. He holds a Masters of Business Administration from Loyola University Chicago’s Graduate School of Business.
Follow Kim D. Blickenstaff:
About Tandem Diabetes Care: Tandem Diabetes Care develops medical devices for the treatment of diabetes offering diabetic insulin pumps for adults and children.
Tricia Moriarty
Vice President of Finance and Administration of Excel Venture Management
Ms. Moriarty is the Vice President of Finance and Administration for Excel Venture Management bringing with her 10 years of private equity experience. In this capacity she oversees the operational, financial and administrative aspects of the firm including financial reporting, human resources, facilities and investor relations. Prior to Excel Venture, Tricia was Director of Finance and Administration for CB Health Ventures (CBHV) where she worked in a similar capacity managing venture funds with $150 million of capital under management. Prior to CBHV, she was a Manager in the Global Income Unit at State Street Corporation where she managed daily operations and client service for clients in the Asia Pacific region. Ms. Moriarty has a BS in Business Administration from Northeastern University where she graduated with honors.
Follow Tricia Moriarty:
About CB Health Ventures, Excel Venture Management: Excel Venture Management builds companies that apply transformative life science technologies to solve problems in healthcare and beyond.
Paul Molloy
President & CEO of ClearFlow
Paul has over twenty years experience of operations, executive management and Board work at public, private and VC funded medical device companies. Two IPO’s at previous companies, particularly as President & Managing Director orchestrating LMA’s successful 2005 SGX listing at a market capitalization of >$300m. LMA was recently acquired by Teleflex in a process that he brokered. Paul was a practicing CRNA until he joined Datascope Corp in NJ in 1989, obtaining his MBA from the University of Chicago’s Booth School of Business and rising through executive positions with leading medical device firms to CEO level in successive start ups, most recently completing the sale of VasoNova to Teleflex Inc. He has extensive global industry connections and has traveled, lived and worked in Asia, Europe and the USA, including substantial experience setting up and managing operations in Australia, Germany, Switzerland, Singapore, China, Japan, India and Latin America as well as serving on the Board of those local subsidiaries.
Follow Paul Molloy:
About ClearFlow: ClearFlow is a medical device company developing technologies to solve clinical problems associated with obstructed catheters.
Clay Larsen
President and CEO, Co-Founder of Vesselon
Mr. Larsen co-founded Vesselon in 2012 and brings over thirty years of executive management, marketing, sales, clinical innovation and engineering/project management in the healthcare industry. Mr. Larsen was a senior executive with FUJIFILM Medical Systems, where he was largely responsible for building the company’s first healthcare software division from the ground up. Mr. Larsen recruited the original senior architects and was instrumental in the development, marketing, commercial release and field support of Fuji’s Synapse® Picture Archive and Communication System (PACS). In a move to Silicon Valley in 1988, Mr. Larsen served in several senior roles at Acuson Corporation culminating as Vice President of New Market Development. Acuson was one of the leading ultrasound technology companies that was later acquired by Siemens. Early in his career he specialized in Sales and Marketing Management of Ultrasound and Nuclear Medicine for Picker International. Mr. Larsen holds a B.S. in Molecular Biophysics and Biochemistry from Yale University.
Follow Clay Larsen:
About Vesselon: Vesselon is a medical device company developing novel therapeutic Immuno-Oncology complexes.
Chris Robinson
Vice President Recruiting of Third Rock Ventures
Chris Robinson joined Third Rock Ventures in 2010. Chris has more than 15 years of research and development-focused recruiting experience in life sciences and high technology. During his executive search career, Chris has focused on senior level executive searches within R&D organizations of both public and private biopharmaceutical and medical device companies. Prior to joining Third Rock Ventures, Chris was the co-founder of Pivotal Search, a boutique life sciences executive search and recruiting consulting practice where he led business development and executed searches. Previous to founding Pivotal, Chris was also one of the founding members of a life sciences R&D practice at another national search firm. Before moving to the life sciences industry Chris was the recruiting manager for a venture-backed technology start-up, Taqua Systems, where he helped them grow from 20 people to 300 people in three locations. Chris holds a BS in Physiology from the University of Massachusetts, was honorably discharged from the United States Marine Corps and he is a Desert Storm veteran.
Follow Chris Robinson:
About Third Rock Ventures: Third Rock Ventures invests in transformational life science companies that show high growth potential
Amit Vohra
Co-Founder, President & CEO of Promaxo
Promaxo is led by Dr. Amit Vohra who is a serial entrepreneur, business strategist and advisor to several healthcare and technology startups. Amit is a Partner in Advanced Biopharma Consulting, a management consultancy offering strategic business development and commercialization services in the life sciences space. He also serves as an advisor to Cricking, MedDx and HealthyX and a strategy consultant to Precision Biopsy and Weinberg Medical Physics. Prior to Promaxo, Amit was the CEO/President of Convergent Life Sciences wherein he took a MRI-US fusion product, for targeted laser ablation of soft tissue cancer, through FDA clearance within 18 months of Company formation. Previously, as VP of Strategy and Operations at Eigen, he led the development and successful commercialization of two class II medical devices in the prostate biopsy space. In 2009, Amit co-founded Navya Biomedical Technologies, a biotechnology company using proprietary polyhydroxy fullerenes (PHF) for non-invasive imaging and destruction of solid tumors. Amit has a Doctorate in Mechanical Engineering from University of Florida, and an Executive MBA (Fuqua Scholar) from Duke University’s Fuqua School of Business.
Follow Amit Vohra:
About 8chili, Neuro42, Promaxo, TriOcula Technologies: Promaxo is commercializing customer-centric MRI systems and robotic guidance tools for live diagnosis and treatment in a physician’s office.
Kathryn Zavala
Vice President, Business Development & Operations of MedTech Innovator
Follow Kathryn Zavala:
About MedTech Innovator: MedTech Innovator is the largest lifescience accelerator in the world for medical device, digital health, and diagnostic companies
Franklin Maddux
Chief Medical Officer and Executive Vice President for Clinical and Scientific Affairs of Fresenius Medical Care North America
Franklin W. Maddux, is the Executive Vice President for Clinical and Scientific Affairs and Chief Medical Officer of Fresenius Medical Care. Frank joined us in 2009 after Fresenius Medical Care acquired a company he founded, Health IT Services Group, a leading-edge Electronic Health Record (EHR) software company. Frank has more than 25 years of health-care experience, including the practice of nephrology. He is a founder of Specialty Care, a leading provider of perfusion and surgical support services. Frank also serves as Clinical Associate Professor of Medicine at the University of North Carolina School of Medicine and formerly practiced nephrology at the Danville (Virginia) Urologic Clinic, serving as its president from 1995 to 2005. He has served on numerous boards and committees involved in developing technology initiatives in both the medical and regional economic development arenas. He received his bachelor’s degree in mathematics from Vanderbilt and an MD degree from the University of North Carolina at Chapel Hill, where he completed his internship, residency, chief residency and nephrology fellowship.
Follow Franklin Maddux:
About Fresenius Medical Care North America: Fresenius Medical Care North America provides healthcare services to people with renal and other chronic conditions.
Uday Kumar
Founder, President, CEO, and Board Member of Element Science
Co-Founder & Board Member at Sympara Medical – Dr. Uday N. Kumar, a cardiologist and cardiac electrophysiologist by training.
Follow Uday Kumar:
About Element Science, Stanford University, Sympara Medical: Element Science is a medical device and digital health start-up that develops lifesaving wearable solutions.
Ahava Stein
Vice President & Regulatory Affairs of Microbot Medical
Ahava Stein is an expert in regulatory affairs, clinical and quality assurance (QA) specializing in FDA and CE submissions with over 20 years of experience working directly with the FDA, Including regulatory submissions for 510(k), PMA, IDE, Pre-IDE, 513(g), and RFD, for a wide variety of innovative, medical devices and participation in PMA Panel meetings. She has managed multicenter, clinical studies, participated in numerous BIMO inspections, clinical site inspections in the US, Europe and Israel. She has extensive experience in implementing QA systems at medical device companies, submitting PMA manufacturing sections and participating in a multitude of QSR and ISO 13485 inspections by the FDA and European Notified Bodies.
Follow Ahava Stein:
About MEDX Ventures Group, Microbot Medical: Microbot Medical is the first medical device company specialized in the researching, designing, developing and commercializing.
Eyal Ben Moshe
Vice President of Research & Development of Microbot Medical
Eyal Ben-Moshe has more than 20 years of experience in research, development and engineering, spanning several disciplines including mechanics, electronics, materials, and managing large Development teams in the IAI (Israel Aerospace Industries). Eyal filled a range of technology leadership roles at companies focusing mainly on medical devices, directing the development of new products from the concept phase through to production. Eyal holds a BSc in Mechanical Engineering and MSc in Biomedical Engineering from the Ben-Gurion University
Follow Eyal Ben Moshe:
About Microbot Medical: Microbot Medical is the first medical device company specialized in the researching, designing, developing and commercializing.
John Putman
President & CTO of Nanotronics Imaging
John Putman is president at Nanotronics Imaging.
Follow John Putman:
About Nanotronics Imaging: Nanotronics Imaging is a microscopy and software company delivering rapid testing and analysis solutions.
Vadim Pinskiy
Vice President of Research and Development of Nanotronics Imaging
Vadim Pinskiy is the vice president of research and development at Nanotronics, where he oversees product development, short-term R&D, and long-term development of AI platforms. Vadim completed his doctorate work in neuroscience, focused on mouse neuroanatomy using high throughput whole slide imaging and advanced tracing techniques. Previously, he earned his master’s in biomedical engineering from Cornell University and his bachelor’s and master’s in electrical and biomedical from the Stevens Institute of Technology. Vadim is interested in applying advanced AI methods and systems to solving practical problems in biological and product manufacturing.
Follow Vadim Pinskiy:
About Nanotronics Imaging: Nanotronics Imaging is a microscopy and software company delivering rapid testing and analysis solutions.
George Palikaras
Founder, President/CEO of Metamaterial Inc.
Founder at Metamaterial Technologies
Follow George Palikaras:
About Metamaterial Inc.: Mastering Light using Smart Materials & Photonics. Changing the way we use, interact and benefit from Light.
Surendar Magar
President and CEO of LifeSignals
Surendar Magar has over 30 years’ experience in the technology industry. He co-invented the Texas Instruments TMS320, the groundbreaking digital signal processing architecture that launched the DSP industry. Later he co-founded Athena Semiconductors, an early developer of the wireless networking platform that would become Wi-Fi; Athena was acquired by Broadcom Corporation.
Follow Surendar Magar:
About LifeSignals: LifeSignals’ offers innovation in wearable biosensor technologies to address a broad set of needs and opportunities throughout healthcare.
Jeffrey Mathers
Vice President, Commercial Technology, Software Engineering, R&D Platforms, and Architecture of Johnson & Johnson
Follow Jeffrey Mathers:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Vaibhav Narayan
Vice President, Digital Health Innovation of Johnson & Johnson
Follow Vaibhav Narayan:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Ravi Parameswar
Vice President, Head of Global Strategic Insights & Analytics of Johnson & Johnson
Follow Ravi Parameswar:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Nicholas Pachuda
Worldwide Vice President,Orthopedic Innovation,External Innovation & Enabling technologies of Johnson & Johnson
Follow Nicholas Pachuda:
About Johnson & Johnson, Peptilogics: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Amy Foley
Vice President, Product Innovation & Delivery of Johnson & Johnson
As Vice President of Product Innovation & Delivery, Amy Foley leads the Johnson & Johnson portfolio of health and wellness capabilities, including new product and service innovation, creation, implementation, operations, customer service and compliance and quality.
Follow Amy Foley:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Jane Adams
Vice President, Federal Government Affairs of Johnson & Johnson
Follow Jane Adams:
About Johnson & Johnson, Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Hartmuth Kolb
Vice President, Neuroscience Biomarkers and Janssen R&D Global Imaging of Johnson & Johnson
Follow Hartmuth Kolb:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Cat Oyler
Vice President, Global Public Health, Tuberculosis of Johnson & Johnson
Cat Oyler serves as vice-president of global public health (GPH) at Johnson & Johnson (J&J), leading the tuberculosis (TB) focus area strategy team (FAST), and as a member of the GPH executive leadership team. In this role, Cat leads the enterprise TB FAST to deliver on J&J’s aspiration to create a world without tuberculosis through ending mortality from multidrug-resistant tuberculosis. Cat previously served as global head of strategy and operations for J&J Innovation (JJI). She had responsibility for aligning the World Without Disease Accelerator, Lung Cancer Initiative, and JJI organizations to accelerate innovation in order to prevent, intercept and cure disease. Before this, Cat held the role of vice-president of strategy and external innovation for Janssen Research and Development, the global R&D arm of Janssen Pharmaceutical Companies of Johnson & Johnson. Here, she directed the development of the company’s long-term ‘A World Without Disease’ strategy, focusing on transforming human health. Additionally, Cat is an Aspen Institute First Mover Fellow and serves as executive sponsor for the university workstream for Women in Science, Technology, Engineering, Math, Manufacturing, and Design (WiSTEM2D).
Follow Cat Oyler:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Tom Heyman
President of Johnson & Johnson Development Corporation
Tom Heyman is President, Johnson & Johnson Development Corporation (JJDC), part of Johnson & Johnson Innovation. As head of JJDC, Tom will chair the board of JJDC, which represents the oldest and most reputable corporate venture fund in the life science industry. Tom will continue his position as CEO of Janssen Pharmaceutica NV in Belgium. He has been in this role since November 2008. Tom continues to be responsible for campus leadership in Beerse, Belgium, as well as the development and execution of a long-term organizational and talent strategy. Tom was appointed Chairman of the Board of Directors, Janssen Pharmaceutica in March 2012. He is a member of the Board of Directors VOKA, the Flemish Industry Association, Belgium, and a member of the Board of Directors of Innotek. As of April 2012, he is a member of the Board of Directors and the General Assembly of IMEC. Tom started his career with Johnson & Johnson in the Legal Department of Janssen Pharmaceutica NV in 1982, where he held a management position supporting legal and licensing activities. In 1990, Tom became Vice-President of Corporate Development at Ortho Pharmaceutical Corporation, and was appointed Head of Global Business Development for the Pharmaceutical Group in 1992, a position he held until March 31 2015. In his 25 years in Business Development, Tom and his Group entered into hundreds of transactions for both early and late stage Pharmaceutical products and technologies including IMBRUVUCA®, daratanumab, INVOKANA®, OLYSIO®, XARELTO®, VELCADE®, etc. He was also responsible for acquiring several key companies for J&J including Tibotec, Centocor, Cougar Pharmaceuticals, Aragon Pharmaceuticals, Covagen and Alios Biopharma. Tom has been a member of the Pharmaceuticals Group Operating Committee (GOC) from 1995 to 2015. From June 2007 until July 2009, Tom also served as Head of the CNS/IM Research & Early Development (RED) organization. He was born in the Congo, Africa, and graduated as Master of Law from the K.U. Leuven in Belgium. He continued with post-graduate studies in International Law in Geneva, Switzerland, and post-graduate studies in Business Management at the University of Antwerp in Belgium.
Follow Tom Heyman:
About Johnson & Johnson Development Corporation: Johnson & Johnson Development Corporation, a venture capital subsidiary, finances technology companies focused on patient health.
Asish Xavier
Vice President, Venture Investments of Johnson & Johnson Development Corporation
Asish Xavier is the Vice President of Venture Investments at joined Johnson & Johnson Innovation – JJDC, Inc. (JJDC) in 2004. Asish is based in Silicon Valley, California. Asish previously worked in business development at BioRexis Pharmaceutical, Inc., which was acquired by Pfizer in 2007. While at BioRexis, Asish assisted the company in raising a $30 million second round of financing. Asish has worked in business development at Structural GenomiX, Inc., acquired by Eli Lilly in 2008, and was a project leader at Message Pharmaceuticals, Inc. Asish received a Ph.D. from the University of Houston and a Master of Business Administration from the Wharton School of the University of Pennsylvania, where he graduated with honors. Asish received a Bachelor of Technology in Chemical Engineering from the Indian Institute of Technology, Kanpur, India. Asish was also a postdoctoral research Fellow in the Department of Chemistry at Johns Hopkins University.
Follow Asish Xavier:
About Cue, ESCAPE Bio, Johnson & Johnson Development Corporation, Legend Biotech, Paige, ViaCyte, XWPharma: Johnson & Johnson Development Corporation, a venture capital subsidiary, finances technology companies focused on patient health.
Marian Nakada
Vice President, Venture Investments of Johnson & Johnson Development Corporation
Marian Nakada, PhD, Vice President, Venture Investments, joined Johnson & Johnson Development Corporation (JJDC) in 2013. She is based in Boston, MA. Previously, Dr. Nakada was Vice President of Strategy & Operations and External Innovation for Johnson & Johnson’s Biotechnology CoE, where she helped drive the development and execution of the biotechnology strategy across Janssen R & D. In her role as External Innovation lead, she nurtured many productive partnerships with external partners in the biotech industry and helped build an external innovation network to complement internal research and support the execution of the Janssen R&D Biologics strategy. Dr. Nakada joined Centocor in 1990, as a scientist, performing basic research related to biologics for inflammatory and cardiovascular indications. In 2001, she took on the leadership of the newly formed Oncology Research group at Centocor. In 2007, Dr. Nakada joined the Business Development group where she participated in executing technology licenses for the Johnson & Johnson pharmaceuticals group. In that role, she identified and championed external technology opportunities to ensure that Centocor’s technologies were competitive with the industry. Dr. Nakada has authored 62 peer reviewed publications and 14 book chapters and reviews. She has a BA in Biology from Harvard College and a PhD in Pharmacology from the University of Pennsylvania.
Follow Marian Nakada:
About Johnson & Johnson Development Corporation, Women in VC: Johnson & Johnson Development Corporation, a venture capital subsidiary, finances technology companies focused on patient health.
Kadir Kadhiresan
Vice President, Venture Investments of Johnson & Johnson Development Corporation
V. Kadir Kadhiresan, PhD, joined Johnson & Johnson Innovation – JJDC, Inc. (JJDC) in 2007 and focuses on investments in medical devices and digital health. Kadir has more than two decades of operational, investment and business development experience. Based in Boston, Kadir works closely with Johnson & Johnson leadership to identify business needs and has responsibility for sourcing, investing and managing venture investment opportunities. He holds board seats for several JJDC portfolio companies. Some of his investments include Coherex Medical (Acquired by Biosense Webster/JNJ), Spinal Modulation (Acquired by St.Jude/ABT), Novocure (NASDAQ: NVCR), Torax Medical (Acquired by Ethicon/JNJ), Neotract (Acquired by Teleflex) and Inspire Medical Systems (NYSE: INSP). Before joining JJDC, Kadir was head of Business Development at Guidant, Inc., now Boston Scientific, Inc., where he led several transactions to access novel medical device technologies.
Follow Kadir Kadhiresan:
About Johnson & Johnson Development Corporation: Johnson & Johnson Development Corporation, a venture capital subsidiary, finances technology companies focused on patient health.
Stacy Feld
Vice President, Consumer Venture Investments of Johnson & Johnson Development Corporation
Stacy received a B.A. in sociology, graduating magna cum laude from the University of Pennsylvania and earned her J.D. from Vanderbilt Law School.
Follow Stacy Feld:
About Johnson & Johnson Development Corporation, Johnson & Johnson Development Corporation: Johnson & Johnson Development Corporation, a venture capital subsidiary, finances technology companies focused on patient health.
Leonide Saad
Founder, President & Chief Executive Officer of Alkeus Pharmaceuticals
Dr. Saad founded Alkeus Pharmaceuticals with the goal of developing sight-saving, transformative medicines for the most serious and untreatable causes of blindness. Prior to Alkeus, he was partner in a boutique life sciences management and consulting firm in New York City, providing business and strategic guidance to biotechnology and pharmaceutical companies. He was previously at Proteus Venture Partners, an early stage, California based venture fund focused on stem cells and regenerative medicine. Dr. Saad holds a PhD focused on tissue engineering from MIT, a certificate of Financial Technology from MIT Sloan School of Management, a MS in Mechanical Engineering from MIT, a BS and MS in Applied Mathematics from University of Paris VI, and is a graduate from Ecole Polytechnique, Paris, with a concentration in organic chemistry and physics.
Follow Leonide Saad:
About Alkeus Pharmaceuticals: Alkeus Pharmaceuticals Inc., a Boston-based startup focused on treatments for serious ophthalmic conditions.
Robert Ford
President & Chief Executive Officer of Abbott
Follow Robert Ford:
About Abbott: Abbott is engaged in pharmaceuticals and manufacturing healthcare products.
Michael Warmuth
Executive Vice President of Abbott
Michael Warmuth is Executive Vice President, Established Pharmaceuticals, focusing on expanding the global market for Abbott’s portfolio of branded generic pharmaceuticals. He was appointed to his current role in November 2012. Most recently, Mr. Warmuth served as Senior Vice President, Established Pharmaceuticals, which previously operated as part of Abbott’s global pharmaceutical business. Mr. Warmuth joined Abbott in 1986 as part of Abbott’s manufacturing professional development program. He served in a variety of management roles including Senior Vice President, Diagnostics, heading Abbott’s global core laboratory Diagnostics business; Vice President and General Manager, Hematology, in Abbott’s Diagnostics business; Vice President, Global Engineering Services; Divisional Vice President of Pharmaceutical Operations; and Divisional Vice President of Corporate Quality Operations. He earned a bachelor’s degree in business administration from the University of Wisconsin-Whitewater and a master’s degree in business administration from Northwestern University.
Follow Michael Warmuth:
About Abbott: Abbott is engaged in pharmaceuticals and manufacturing healthcare products.
Heather Mason
Executive Vice President, Nutritional Products of Abbott
Heather Mason is Executive Vice President, Nutritional Products. She was appointed to her current role in May 2015. Previously, she served as Executive Vice President, Global Commercial Operations, Abbott Nutrition. Ms. Mason joined Abbott in 1990. She held a number of positions in Abbott’s U.S. pharmaceutical business, including oversight of Abbott’s specialty pharmaceuticals, its diabetes/metabolics and oncology franchises, and managed health care. Ms. Mason also served as Vice President, International Marketing, and Vice President, Latin American Operations, in Abbott’s international pharmaceutical business. Immediately prior to assuming her role in Abbott’s Nutrition business in 2014, Ms. Mason served as Senior Vice President, Abbott Diabetes Care. Prior to joining Abbott, Ms. Mason worked for Quaker Oats and FMC Corporation. She is an advisory board member of the Healthcare Businesswomen’s Association. She earned a bachelor’s degree in engineering from the University of Michigan and a master’s degree in business administration from the University of Chicago.
Follow Heather Mason:
About Abbott: Abbott is engaged in pharmaceuticals and manufacturing healthcare products.
Corlis Murray
Senior Vice President, Quality Assurance, Regulatory & Engineering Services of Abbott
Corlis Murray is Senior Vice President, Quality Assurance, Regulatory and Engineering Services. She was appointed to her current position in February 2012. Previously, she served as Vice President, Global Engineering Services. Ms. Murray joined Abbott in 1989. Since then, she has held a number of management positions in quality, operations and engineering in Abbott’s Diagnostics and Nutrition businesses. In Abbott Nutrition, she served as Divisional Vice President, Quality Assurance; Divisional Vice President, Manufacturing; and Divisional Vice President, Operations Services. Prior to joining Abbott, Ms. Murray worked at Recognition Equipment and Xerox Corporation. She is a board member of The Clara Abbott Foundation. She earned a bachelor’s degree in mechanical engineering from Southern University in Baton Rouge, Louisiana.
Follow Corlis Murray:
About Abbott: Abbott is engaged in pharmaceuticals and manufacturing healthcare products.
John Capek
Executive Vice President of Abbott
John Capek, Ph.D., is Executive Vice President, Ventures. Dr. Capek was appointed to his current position in June 2015. In this role, he leads Abbott’s venture investment organization as well as new ventures, including Abbott Electrophysiology. Previously, he had served as Executive Vice President, Medical Devices, and Senior Vice President, Abbott Vascular, heading up Abbott’s global vascular business. Before joining Abbott, Dr. Capek served in various management roles at Guidant Corporation, including president, Guidant Vascular Intervention and vice president and general manager of Bioabsorbable Vascular Solutions. He also served as vice president and general manager of Guidant Germany and vice president, marketing, Guidant Cardiac Rhythm Management Group. Before joining Guidant, Dr. Capek was manager of New Product Technology at Eli Lilly & Company. He has a bachelor’s degree in biomedical engineering, a master’s degree in biomedical engineering, a master’s degree in electrical engineering, a Ph.D. in biomedical engineering and a master’s degree in business administration from Rensselaer Polytechnic Institute.
Follow John Capek:
About Abbott: Abbott is engaged in pharmaceuticals and manufacturing healthcare products.
Roger Bird
Senior Vice President, U.S. Nutrition of Abbott
Roger Bird is Abbott’s Senior Vice President, U.S. Nutrition. He was appointed to this role in February 2015. Prior to assuming his current position, Roger served as Divisional Vice President, General Manager for our Nutrition business in China and Hong Kong. Roger came to Abbott in 1983 from the Dial Soap Company, where he worked as a sales representative. He joined Abbott as Trade Sales Manager in our Nutrition organization, and has served in this business throughout his Abbott career, contributing to our company’s success in both the U.S. and Asia. While leading Abbott’s nutrition business in China, he oversaw the successful launch of Similac Eleva and Similac Qinti, two infant formula products that significantly strengthened Abbott’s presence in this important market. Throughout his career, Roger has taken real pride in contributing to the Abbott Nutrition mission of providing high-quality products that help improve the lives of people of all ages, all around the world. In addition to his responsibilities with Abbott. Roger serves on the Board of the Grocery Manufacturers Association. Roger earned his bachelor’s degree in Business Management from Weber State University in Ogden, Utah.
Follow Roger Bird:
About Abbott: Abbott is engaged in pharmaceuticals and manufacturing healthcare products.
Steve Fussell
Executive Vice President, Human Resources of Abbott
Steve Fussell is Executive Vice President, Human Resources. He was appointed in February 2013. Mr. Fussell joined Abbott in 1996, as Divisional Vice President, Compensation and Benefits. He was promoted to Vice President, Compensation and Development in 1999, and to Senior Vice President, Human Resources in 2005. Prior to Abbott, he held human resources leadership positions at Nestlé and Shell. Mr. Fussell is Chairman of the Board and President of the Clara Abbott Foundation and a board member of the Abbott Fund. He is an author and speaker on a wide variety of subjects and has served as a guest lecturer at Cornell and other universities. In 2010, he was named to the HR Honor Roll by Human Resources Executive magazine. He earned a bachelor’s degree from Louisiana State University in Baton Rouge.
Follow Steve Fussell:
About Abbott: Abbott is engaged in pharmaceuticals and manufacturing healthcare products.
Jean-Yves Pavée
Senior Vice President of Abbott
Jean-Yves Pavée is Senior Vice President, Developed Markets for Abbott’s Established Products Division. He was appointed to his role in July 2013. Previously, he served as Divisional Vice President, EMEA East, and Division Vice President, Pharmaceuticals, Europe South. Mr. Pavee joined Abbott in 1992, after serving as European Sales Manager, France for Aguettant, S.A. Mister Pavée received his undergraduate degree from the Ecole Supérieure des Sciences Commerciales d’Angers, France; and his MBA from HEC Paris MBA, Jouy-en-Josas, France.
Follow Jean-Yves Pavée:
About Abbott: Abbott is engaged in pharmaceuticals and manufacturing healthcare products.
Brian Yoor
Senior Vice President Finance & Chief Financial Officer of Abbott
Brian Yoor is Senior Vice President Finance and Chief Financial Officer. He was appointed to his current position in June 2015. He previously served as Vice President, Investor Relations. Brian joined Abbott in August 1997, and held various financial management positions of increasing responsibility, including Controller positions in the pharmaceutical, nutrition, and diagnostic businesses, before being asked to lead Abbott’s Investor Relations effort in January 2013. Prior to joining Abbott, Brian was a certified public accountant with Arthur Andersen and held financial positions in the consumer industry with the Scotts Company and Newell Rubbermaid. “In Abbott Finance, we are the stewards that enable financial reliability and growth for Abbott, “ Says Brian. “ A strong, growing company is better able to help people around the world live their healthiest lives.” Brian serves on the board of the Clara Abbott Foundation. He is a member of NIRI, the National Investor Relations Institute. He earned his bachelor’s degree in accounting at the University of Toledo in Ohio.
Follow Brian Yoor:
About Abbott: Abbott is engaged in pharmaceuticals and manufacturing healthcare products.
Hubert L. Allen
Executive Vice President, General Counsel & Secretary of Abbott
Hubert L. Allen is Executive Vice President, General Counsel and Secretary. He was appointed to his current role in January 2013. Previously, he served as Divisional Vice President and Associate General Counsel, Established Pharmaceuticals. Mr. Allen joined Abbott in 2006 as Senior Counsel, supporting the Pharmaceutical Products Division. He has held various positions within the legal department, including Divisional Vice President and Associate General Counsel, Pharmaceutical Products Group; Section Head, Nutrition Legal Operations; and Division Counsel, supporting the Pharmaceutical Products Division. Prior to joining Abbott, Mr. Allen was Assistant General Counsel for McKesson Corporation. He graduated with a bachelor’s degree from the College of Social Studies at Wesleyan University in Middletown, Connecticut; a master’s degree in Politics from Princeton University in Princeton, New Jersey, and a juris doctorate from Yale Law School in New Haven, Connecticut.
Follow Hubert L. Allen:
About Abbott: Abbott is engaged in pharmaceuticals and manufacturing healthcare products.
Thomas Frinzi
Senior Vice President of Abbott
Thomas Frinzi is Senior Vice President of Abbott’s vision business, which includes a broad ophthalmology portfolio across the areas of cataracts, refractive surgery (LASIK) and eye health products. He was appointed to his position in January 2016. Prior to joining Abbott, Mr. Frinzi held a number of leadership positions in ophthalmology and medical device companies. Most recently, he served as President and CEO of WaveTec Vision, a developer of surgical systems for eye surgery. He also held senior positions in commercial operations, business development, and sales and marketing at Bausch & Lomb Surgical, Refractec and Johnson & Johnson. In recognition of his leadership, expertise and vision in the field, Mr. Frinzi was awarded the 2015 Ophthalmology Innovation Award by the Ophthalmology Innovation Summit. He earned a bachelor’s degree in political science from the University of Tampa.
Follow Thomas Frinzi:
About Abbott: Abbott is engaged in pharmaceuticals and manufacturing healthcare products.
Jason Gray
Vice President of Portfolio Operations of LaunchCapital
Follow Jason Gray:
About LaunchCapital: LaunchCapital was founded in January 2008 with a mission to help entrepreneurs gain quick access to seed capital and mentorship.
John Barnhill
Vice President of Global Marketing & Business Development of OmniGuide
John M. Barnhill joined OmniGuide Holdings, Inc. in October 2016 as Vice President of Global Marketing & Business Development. Prior to joining OmniGuide, Mr. Barnhill held a similar position with RF Surgical, Inc., an early-stage medical technology company that was recently acquired by Medtronic. Prior to that, Barnhill was with Edwards Lifesciences where in over 10 years he held several positions of increasing responsibility including Product Management, New Product Development, Clinical Marketing, Corporate Strategy and Business Development. Mr. Barnhill also held a marketing leadership position with SenoRx, where he grew the company’s breast cancer therapy portfolio, contributing to the successful exit of the company. Mr. Barnhill holds a B.A. in Business Finance from the University of Southern California’s Marshall School of Business and an MBA from the University of California Irvine’s Paul Merage School of Business.
Follow John Barnhill:
About OmniGuide: OmniGuide is a medical device company developing and commercializing minimally-invasive surgical tools.
Ajay A. Bhave
Vice President of Operations of OmniGuide
Ajay A. Bhave joined OmniGuide Surgical, Inc., in August 2016 as the Vice President of Operations. Mr. Bhave has over 32 years’ experience as an Engineering, Technology and Operations leader mostly in the medical device industry. During his career, Mr. Bhave has been instrumental in releasing over 30 new medical products in the global market, achieved $30M+ savings via value engineering & supplier driven productivity and has been involved with 8 successful acquisitions. Mr. Bhave most recently served as the Corporate Vice President of Global Engineering and a Company Officer at Natus Medical Inc., wherein he was responsible for all aspects of new product development from concept to commercial release to end of life. From 1990 to 2011, Mr. Bhave held various positions of responsibilities, starting as an acoustic design engineer with subsequent senior management positions in engineering & technology, supply chain management and plant operations, both at the local as well as global level at General Electric Healthcare. Mr. Bhave holds a Master’s degree in Mechanical Engineering from the University of Lowell, Massachusetts.
Follow Ajay A. Bhave:
About OmniGuide: OmniGuide is a medical device company developing and commercializing minimally-invasive surgical tools.
Sanket Baralay
President & CEO of FIGMD
Sanket is a Health IT expert, innovator and entrepreneur. As the head of FIGmd he has pioneered groundbreaking products, processes and services and has established partnerships with some of the country’s largest medical societies. Prior to FIGmd, Sanket led business and technology companies that focused on developing and delivering solutions for the healthcare industry.
Follow Sanket Baralay:
About FIGMD: FIGMD is a U.S.-based provider of healthcare quality measurement and improvement solutions.
Bob Colloton
Vice President of Sales & Marketing of Neuravi
Follow Bob Colloton:
About MIVI Neuroscience, Neuravi: Neuravi provides medical products and services.
Steve Pham
Vice President of Clinical and Research Affairs of Eko Health
Steve Pham is a practicing emergency medicine physician, the head of medical and research affairs at Eko, and a new father. His passion is translating between digital and clinical insights.
Follow Steve Pham:
About Eko Health: Eko develops AI-powered digital tools to detect and monitor heart and lung disease
Rick Tolin
President, Lubrizol Advanced Materials of The Lubrizol Corp
Rick Tolin is corporate senior vice president and president of Lubrizol Advanced Materials. Mr. Tolin joined the company in 1993 and has held positions of increasing responsibility in sales, marketing, and international business management within Lubrizol’s coatings and personal care businesses. In 2011, he was named vice president and general manager of the personal and home care division of Lubrizol Advanced Materials. He was appointed to his current position in 2016. Prior to joining Lubrizol Mr. Tolin worked at specialty chemical firms RITA Corporation and Carroll Scientific in technical, sales and business management roles. Mr. Tolin attended St. Joseph’s College and the University of Notre Dame where he received Bachelor of Science degrees in Physics and in Mathematics.
Follow Rick Tolin:
About The Lubrizol Corp: A Berkshire Hathaway company, is a technology-driven global company
Cameron Jacox
Vice President, Growth of Lark
Follow Cameron Jacox:
About Lark: Lark is a digital health startup that provides virtual care through AI coaching, smart devices, and tele-monitoring.
William Gish
Vice President, Corporate Development of Cerner
As Senior Director at Cerner Corporation, Bill Gish leads all business development activities at the company. He previously was Director of PowerWorks, Cerner’s Ambulatory business unit. Before his ten years with Cerner, Bill held multiple leadership positions in Finance, IT Project Development and Operations at Sprint. He earned a Bachelor’s degree in Business Administration (Accounting and Finance) from Kansas State University.
Follow William Gish:
About Cerner: Cerner is a supplier of healthcare information technology solutions, services, devices, and hardware.
Paul Stein
Vice President of Software Engineering of Cerner
Paul Stein is the vice president of software engineering at Cerner Corporation.
Follow Paul Stein:
About Cerner: Cerner is a supplier of healthcare information technology solutions, services, devices, and hardware.
Robert Desantis
Executive Vice President Chief Product Officer of Intuitive Surgical
Bob DeSantis joined Intuitive Surgical in January 2013 as Vice President, Research and Development, Instruments and Accessories Engineering. In November 2015, Mr. DeSantis was promoted to the position of Senior Vice President, Instruments and Accessories. In this position, Mr. DeSantis is responsible for managing the development of new technology from design to market as well as production engineering support for the instrument and accessory portfolio. Prior to joining Intuitive Surgical, Mr. DeSantis spent almost twenty years in the medical device industry, holding positions at several companies, including US Surgical and most recently at Covidien, where he last served as the Vice President, Research and Development for the mechanical and energy instrument businesses. Mr. DeSantis holds a B.S. and M.S.in Mechanical Engineering from the State University of New York at Buffalo. Mr. DeSantis also holds a certificate in Innovation Management from MIT.
Follow Robert Desantis:
About Intuitive Surgical: The da Vinci Surgical System is changing the experience of surgery for patients around the world.
Dave Rosa
Executive Vice President & Chief Business Officer of Intuitive Surgical
Dave J. Rosa joined Intuitive Surgical in March 1996 and has held leadership positions in Engineering, Clinical Development, Marketing and Product Development. In 2015, Mr. Rosa was appointed as Executive Vice President and Chief Commercial Officer. In 2013, Mr. Rosa assumed the position of Senior Vice President, Scientific Affairs and, in 2014, he was appointed as Executive Vice President and Chief Scientific Officer. He has been a passionate supporter and evangelist of da Vinci technology since its inception. Prior to joining Intuitive Surgical, Mr. Rosa contributed to the development of trans-esophageal transducers for Acuson Corporation. He graduated magna cum laude with a B.S.in Mechanical Engineering from California Polytechnic University at San Luis Obispo. He also holds a M.S. in Mechanical Engineering from Stanford University.
Follow Dave Rosa:
About Intuitive Surgical: The da Vinci Surgical System is changing the experience of surgery for patients around the world.
Gillian Duncan
Senior Vice President, Professional Education & Program Services – Worldwide of Intuitive Surgical
Gillian Duncan, Ed.D., joined Intuitive Surgical in December 2006 as an Education Manager. After holding several positions of increasing responsibility in clinical, product and professional education, Dr. Duncan was promoted to the position of Vice President, da Vinci® Professional Education & Program Services – Worldwide in August 2015. In this role, Dr. Duncan is responsible for leading the company’s high-quality, worldwide Customer Training, Genesis, Lab Services and Clinical and Product Education programs. Prior to joining Intuitive Surgical, Dr. Duncan held both teaching and research positions at Columbia University and California State University, East Bay. Dr. Duncan holds a B.A. in Rhetoric from the University of California, Berkeley, and master’s and doctorate degrees in Applied Physiology from Columbia University.
Follow Gillian Duncan:
About Intuitive Surgical: The da Vinci Surgical System is changing the experience of surgery for patients around the world.
Myriam Curet
Executive Vice President & Chief Medical Officer of Intuitive Surgical
Myriam J. Curet, M.D. joined Intuitive Surgical in December 2005, as Chief Medical Advisor. In February 2014, Dr. Curet was promoted to the position of Chief Medical Officer. Dr. Curet also held a faculty position as Professor of Surgery at Stanford University. Since October 2010, she has served as a Consulting Professor of Surgery at Stanford University with a part time clinical appointment at the Palo Alto Veteran’s Administration Medical Center. Dr. Curet received her M.D. from Harvard Medical School and completed her general surgery residency program at the University of Chicago. She then worked for the Indian Health Service for four years before finishing her Surgical Endoscopy fellowship at the University of New Mexico. She was on the faculty at the University of New Mexico for six years prior to joining the Stanford University Department of Surgery in 2000.
Follow Myriam Curet:
About Intuitive Surgical: The da Vinci Surgical System is changing the experience of surgery for patients around the world.
Craig Child
Sr. Vice President, Human Resources of Intuitive Surgical
Craig Child joined Intuitive Surgical in May 2001 as a Recruiting Consultant. In March 2015, Craig Child was promoted to the position of Vice President, Human Resources. Prior to this role, Mr. Child has held several key positions since the inception of the human resources organization at Intuitive Surgical, playing an instrumental role in the development of key human resources functions. Prior to joining Intuitive Surgical, Mr. Child held positions in human resources at Adobe and Informix. Mr. Child holds a B.A. in Psychology from the University of Oregon and a M.B.A from Colorado State University.
Follow Craig Child:
About Intuitive Surgical: The da Vinci Surgical System is changing the experience of surgery for patients around the world.
Charles Jones
Senior Vice President, Design and User Experience of Intuitive Surgical
Charles Jones joined Intuitive Surgical in April 2016 as the Senior Vice President, Design and User Experience. In this role, Mr. Jones is responsible for leading the company’s efforts to blend leading-edge technology with enhanced human-centered design thinking and driving a consistent design experience for Intuitive products and services. Prior to joining Intuitive Surgical, Mr. Jones has held several key leadership roles at Whirlpool Corp., Xerox Corp. and Herman Miller, and most recently served as the Chief Design and Technology Officer for Newell Rubbermaid. Mr. Jones has received several international design awards, including the prestigious Smithsonian National Design Award, and holds several patents. Mr. Jones is an honors graduate from Purdue University with degrees in Industrial Design and Human Factors Engineering.
Follow Charles Jones:
About Intuitive Surgical: The da Vinci Surgical System is changing the experience of surgery for patients around the world.
Todd Helman
Vice President of Sales of Blockade Medical
Todd is the US National Sales Director at Blockade Medical and has more than 13 years of sales and sales leadership experience working within the medical and interventional neurovascular space. Prior to working at Blockade Medical, Todd held sales leadership roles at Stryker Neurovascular, Concentric Medical and Kyphon Inc. During his time in those positions he successfully recruited, developed and lead teams to multiple annual sales awards. Todd has a rounded experience selling both first to market technologies as well as selling products into more mature and highly competitive product classes. Todd holds a Bachelor of Arts from the University of Maryland and is an avid endurance athlete who competes primarily in Ironman and half Ironman events.
Follow Todd Helman:
About Blockade Medical: Founded in 2011, Blockade Medical is a privately held company dedicated the development of catheter based therapeutic devices for the
Charles Yang
Vice President of Quality Assurance & Regulatory Affairs of Blockade Medical
Charles is currently the Vice President of Quality Assurance and Regulatory Affairs at Blockade Medical. He has been in the medical device industry for over 15 years in the quality and regulatory field with extensive experience in achieving product approvals in a timely manner. Charles has been successful in achieving multiple product approvals through CE Mark, 510K and other regulatory processes all over the world. He has a diversified portfolio of working in start-up companies and large corporations which has allowed him to gain the experience to build efficient quality systems that meet the needs of the medical device industry. Prior to joining Blockade Medical, Charles worked at various medical device companies which include Acutus Medical, MindFrame Inc. (acquired by Covidien), Ablation Frontiers (acquired by Medtronic) and Edwards LifeSciences. Charles received a B.S. in Bio-engineering at the University of California, San Diego.
Follow Charles Yang:
About Blockade Medical: Founded in 2011, Blockade Medical is a privately held company dedicated the development of catheter based therapeutic devices for the
Ryan Solomon
Vice President of Marketing & Business Development of Blockade Medical
Ryan is the Director of Global Marketing and Business Development at Blockade Medical and has more than 10 years of medical sales and marketing expertise including extensive interventional neurovascular experience. Ryan has successfully launched many products in the neurovascular field including launching the first flow diversion device in the United States while serving as the Group Marketing Manager at Covidien Neurovascular and global launches of multiple coil lines as a Sr. Product Manager at MicroVention. His previous roles have also included Associate Marketing Manager at Karl Storz Endoscopy, Sr. Clinical Sales Specialist at Glaxo Smith Kline, and a Professional Sales Representative for Boehringer Ingelheim. Ryan received a B.S. in Business Administration from the University of California, Riverside and a M.B.A. from the University of California, Irvine.
Follow Ryan Solomon:
About Blockade Medical: Founded in 2011, Blockade Medical is a privately held company dedicated the development of catheter based therapeutic devices for the
Jeffrey Brewer
President & CEO of Bigfoot Biomedical
Follow Jeffrey Brewer:
About Bigfoot Biomedical: Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes.
Billoo Rataul
President & CEO of Paramit Corporation
Billoo Rataul is the President & CEO at Paramit Corporation.
Follow Billoo Rataul:
About Paramit Corporation: Paramit designs and manufactures medical devices and life science instruments.
Bhavin Shah
Vice President of Engineering and Quality of Paramit Corporation
Bhavin joined Paramit in 2014. Bhavin brings with him over 20 years of experience in developing products involving hardware and software/firmware for multiple industries. Prior to Paramit, Bhavin spent 5 years at Diamond Systems, managing engineering teams developing high precision digital and analog PCBAs and 9+ years with Asyst Technologies. Bhavin has a BSEE from the Mumbai University(India) and a Post Graduate Diploma in Advanced Computing from C-DAC (India).
Follow Bhavin Shah:
About Paramit Corporation: Paramit designs and manufactures medical devices and life science instruments.
Francesco Grieco
Vice President of Operations of Paramit Corporation
Francesco Grieco is the VP of Operations at Paramit Corporation.
Follow Francesco Grieco:
About Paramit Corporation: Paramit designs and manufactures medical devices and life science instruments.
Giulio Ruffini
President, CSO and co-founder of Neuroelectrics
Dr. Giulio Ruffini is the CEO and CTO of Starlab and the president and CSO of Neuroelectrics. He obtained a BA in Mathematics & Physics from Berkeley and a PhD in theoretical physics from UC Davis/LANL in 1995. In 2000 he founded Starlab to transform science into high-impact technologies.
12 years later he founded Neuroelectrics, a company which combines high-precision multichannel stimulation technologies with advanced biophysical and neuro-computational models.
For the past 15 years, Giulio has been developing technology for and researching the use of non-invasive brain monitoring and brain stimulation techniques, with a focus on EEG and transcranial current stimulation. His paper on brain-to-brain telepathy communication was the top 10 most shared papers of 2014. He is currently leading or involved in several European programs such as Galvani ERC Synergy, STIPED or Neurotwin.
Follow Giulio Ruffini:
About Neuroelectrics: Neuroelectrics is a digital brain health company that diagnoses and treats brain disorders with personalized neuromodulation, and improves overall brain health.
Kurt Graves
President & CEO of Intarcia Therapeutics
Follow Kurt Graves:
About Intarcia Therapeutics: Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
David Franklin
Vice President, Commercial Operations of Intarcia Therapeutics
Mr. Franklin joined Intarcia in March 2006 as Vice President, Commercial Operations. Prior to joining Intarcia, Mr. Franklin was Senior Vice President, US Business Unit and Acting Senior Vice President, Global Marketing for Idenix Pharmaceuticals. As head of the US Business from March 2005 through March 2006, Mr. Franklin developed and executed plans for the commercialization of telbivudine, an antiviral for the treatment of chronic hepatitis B, and built the US Business Unit, an organization comprising approximately 40 Medical, Marketing and Sales personnel. From June 2003 until March 2005, Mr. Franklin served as Vice President, Commercial Operations, leading the Idenix Global Marketing group, directing brand development for telbivudine and for a phase II hepatitis C drug candidate and leading commercial efforts to form a global co-promotion and licensing alliance with Novartis AG. Prior to these responsibilities, Mr. Franklin held positions of increasing responsibility with Idenix as Executive Director, Marketing and Corporate Communications and Director, Marketing and played key roles in multiple private and public financing transactions and in business development and licensing transactions. Prior to joining Idenix in 1998, Mr. Franklin was Senior Product Manager, HIV Products for Bristol-Myers Squibb Co. with responsibility for Zerit and Videx, two antiviral therapies for the treatment of HIV infection. Prior to joining the HIV Products Division, Mr. Franklin held sales and sales administration positions within the Bristol-Myers Squibb Oncology Division from 1990 to 1995, responsible for sales force support, incentive compensation and alliance management. Mr. Franklin received a BA from Gettysburg College in 1988.
Follow David Franklin:
About Intarcia Therapeutics: Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Ved Srivastava
Vice President, Chemistry of Intarcia Therapeutics
Follow Ved Srivastava:
About Intarcia Therapeutics, U.S. Pharmacopeial Convention (The United States Pharmacopeial Convention): Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Andrew Young
Vice President & Chief Scientific Officer of Intarcia Therapeutics
Dr. Young joined Intarcia in September 2015 as Vice President and Chief Scientific Officer. Dr. Young is most recognized for his role in the discovery and development of peptide therapeutics for metabolic diseases. Prior to its acquisition by Intarcia, he co-founded and was CSO of Phoundry Pharmaceuticals Inc., a company dedicated to rendering peptides sufficiently potent for incorporation into innovative delivery systems such as Intarcia’s proprietary mini-pump technology. Dr. Young entered industry from academia 26 years ago as the founding physiologist at Amylin Pharmaceuticals, Inc. There he pioneered work that illuminated the role of the gut in blood glucose control. He co-led different phases of the development of pramlintide and exenatide, first-in-class medicines for the treatment of diabetes. His roles at Amylin included VP of Research and Senior Research Fellow. In 2008 he co-founded Satiogen Inc., a San Diego startup related to bile salt stimulation of gut hormone secretion, before joining GlaxoSmithKline in RTP, NC, as Head of Enteroendocrine Biology. At GSK he fostered the development of peptide therapeutics as well as non-absorbed medicines acting at gut targets. In 2015 he co-founded Phoundry Pharmaceuticals with five former GSK colleagues. Dr. Young received his medical degree as well as graduate science degrees from the University of Auckland School of Medicine, New Zealand, where he also taught physiology. He worked as a Fogarty Fellow for the NIH in Phoenix AZ, studying diabetes in Pima Indians. He worked as a Von Humboldt Fellow at the Max Planck Institute in Bad Nauheim, FRG, studying sensory neurophysiology. He has participated in the development of five drugs that were commercialized, written over 100 original papers and 37 book chapters or books, and is an inventor on 56 issued US patents.
Follow Andrew Young:
About Intarcia Therapeutics, Satiogen Pharmaceuticals: Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
